Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2007
04/25/2007CN1951489A Chinese medicinal composition for treating calculi and preparation method thereof
04/25/2007CN1951486A A medicament for treating bacterial infection of urinary tract and preparation method thereof
04/25/2007CN1951470A Medicament for treating chronic prostatitis and prostatic hyperplasia
04/25/2007CN1951457A Chinese medicinal preparation for treating proteinuria caused by diabetic nephropathy and preparation method thereof
04/25/2007CN1951390A Pharmaceutical compositions comprising colloidal silicon dioxide
04/25/2007CN1951380A Medical usage of salvianolic acid B salt and total salvianolic acid
04/25/2007CN1951372A Solid oral dosage forms comprising valsartan and HCTZ
04/25/2007CN1951223A Low-protein food for therapy and preparation method thereof
04/25/2007CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89)
04/25/2007CN1312165C Aryl 5-thio-beta-D-glucopyranoside derivatives and remedies for diabetes containing the same
04/25/2007CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use
04/25/2007CN1312147C Substituted benzopyrans compounds as selective estrogen receptor-beta agonists
04/25/2007CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
04/25/2007CN1312120C Adamantane derivatives
04/25/2007CN1312116C Calcium acceptor active compound
04/25/2007CN1311870C Interleukin 6 production inhibitor
04/25/2007CN1311828C Use of CGMP phosphodiesterase inhibitor for treating sexual impotence
04/24/2007USRE39585 Administering streptococcus thermophilus in admixture withLactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum or Bifidobacterium breve
04/24/2007US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents
04/24/2007US7208527 Potassium channel modulators
04/24/2007US7208520 Crystals of hydroxynorephedrine derivative
04/24/2007US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith
04/24/2007US7208501 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders
04/24/2007US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
04/24/2007US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones
04/24/2007US7208279 Method for identifying inhibitors of G protein coupled receptor signaling
04/24/2007CA2281471C Process for preparing eprosartan
04/20/2007CA2562249A1 Anf analogue
04/19/2007WO2007044559A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids
04/19/2007WO2007043653A1 Benzimidazole-5-carboxamide derivative
04/19/2007WO2007043652A1 2-thienylurea derivative
04/19/2007WO2007043568A1 S1p3 receptor antagonist
04/19/2007WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN
04/19/2007WO2007017544A3 Method of obtaining 3,3-diphenylpropylamines
04/19/2007WO2007009758A3 2r,4s) -4- (4-acetyl-3-hydroxy-1-piperazinyl) -n- { (1r) -1- [3, 5-bis (trifluoromethyl) phenyl] ethyl} -2- (4-fluoro-2-methylphenyl) -n-methyl-1-piperidine-carboxamide as tachykinin receptor antagonist
04/19/2007WO2006059764A3 Enhancer of the effect of adrenocorticoid, comprising gum arabic
04/19/2007WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
04/19/2007WO2005056802A3 Materials and methods relating to cell cycle control
04/19/2007US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
04/19/2007US20070088033 Diaryl Substituted Pyridinones
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007US20070088020 Agonists to a cannabinoid type 2 receptor; antiinflammatory agents; immunosuppressants; nephritis
04/19/2007US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3
04/19/2007US20070087970 Use of C-reactive protein to treat immune complex-mediated renal disease
04/19/2007US20070087969 Wound healing and treatment of fibrosis
04/19/2007CA2626011A1 S1p3 receptor antagonist
04/19/2007CA2624677A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids
04/18/2007EP1775297A2 Adenosine receptor antagonists and methods of making and using the same
04/18/2007EP1775289A1 Novel imidazolidine derivatives
04/18/2007EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor
04/18/2007EP1774967A1 Solid oral dosage forms comprising valsartan
04/18/2007EP1773867A2 Proteinaceous compounds and uses therefor
04/18/2007EP1773757A1 Trpv1 agonists, formulations containing them and uses thereof
04/18/2007EP1773406A2 Method for screening agents against human prostate disease
04/18/2007EP1773357A2 Compositions and methods of use of dimer digallates
04/18/2007EP1773335A2 Nanoparticle dispersion containing lactam compound
04/18/2007EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
04/18/2007EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
04/18/2007EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3
04/18/2007EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
04/18/2007EP1352063B1 Receptor nucleic acids and polypeptides
04/18/2007EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase
04/18/2007EP1137408B1 Agent for lowering endothelin levels
04/18/2007EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease
04/18/2007EP1007080B1 Formulation for the sustained release of peptide agonists and analogues of GnRH
04/18/2007CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
04/18/2007CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound
04/18/2007CN1947783A Herb medicine composition contg. Touhualiao (polygonaceae), prepn. method and use thereof
04/18/2007CN1947781A Sugar-free traditional Chinese medicine granules for treating lithangiuria and its prepn. method
04/18/2007CN1947757A Leave of glutinous rehmannia extractive, its prepn. method and use, medicines prepd. with said extractives
04/18/2007CN1947756A Formula of seven herbs medicine composition for relieving internal heat and invigorating blood circulation, its prepn. process and use
04/18/2007CN1947749A Medicine composition contg. Poria cocos and Touhualiao (polygonaceae)
04/18/2007CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist
04/18/2007CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives
04/18/2007CN1310916C Hetero-bicyclic compounds
04/18/2007CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative
04/18/2007CN1310657C Compound lycopene formulation for men and preparation process thereof
04/17/2007US7205417 Spiro compounds
04/17/2007US7205386 Truncated CD200
04/17/2007US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives
04/17/2007US7205309 Obesity therapy; administering orlistat
04/17/2007US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders
04/17/2007US7205151 Antiinflammatory agents; skin disorders
04/17/2007US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders
04/17/2007US7205005 Comprises a flavones extract and polysaccharides
04/17/2007CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors
04/17/2007CA2348725C Vitamin d analogues
04/17/2007CA2341690C Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
04/17/2007CA2271085C Indolecarboxylic compounds and their use as pharmaceutical compounds
04/12/2007WO2007041506A1 Purine formulations and methods for managing disorders
04/12/2007WO2007041023A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
04/12/2007WO2007040966A1 Normalization or remission of microalbuminuria
04/12/2007WO2007040231A1 Quinazoline derivative and pharmaceutical
04/12/2007WO2007040082A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same
04/12/2007WO2007039909A2 Compositions and methods for treatment of renal failure
04/12/2007WO2007039884A1 3 -azabicyclooctane derivatives as muscarinic receptor antagonists
04/12/2007WO2007039809A1 Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione
04/12/2007WO2007039075A2 Pde inhibitors and combinations thereof for the treatment of urological disorders
04/12/2007WO2007038995A1 Factor h for the treatment of chronic nephropathies and production thereof
04/12/2007WO2007016385A3 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators